Study name | Park DI 2016 |
Title | Purine and pyrimidine metabolism: convergent evidence on chronic antidepressant treatment response in mice and humans |
Overall design | DBA/2J mice were treated for 28 days with paroxetine and assessed their behavioral response with the forced swim test (FST). Paroxetine-treated long-time floating (PLF) and paroxetine-treated short-time floating (PSF) groups were stratified as proxies for drug non-responder and responder mice, respectively. Proteomics and metabolomics profiles of PLF and PSF groups were acquired for the hippocampus and plasma to identify molecular pathways and biosignatures that stratify paroxetine-treated mouse sub-groups. All the mice were divided into 2 groups (n = 8 in each group): (1) control group (vehicle), (2) paroxetine group (paroxetine treatment at the dose of 5 mg/kg twice a day). Paroxetine group were divided into responder (short-time floating, PSF) and non-responder (long-time floating, PLF) mice according to their forced swim test floating time. Five samples per group were used for metabonomic analysis. |
Type5; | |
Data available | Unavailable |
Organism | Mouse; DBA/2J mouse; |
Categories of depression | Healthy individuals; Healthy individuals; Healthy individuals; |
Criteria for depression | Forced swimming test, female urine sniffing test |
Sample size | 10 |
Tissue | Central; Brain; Hippocampus; Central; Brain; Prefrontal cortex; Peripheral; Blood; Plasma; |
Platform | MS-based; LC-MS: Prominence UFLC high-performance liquid chromatography system (Shimadzu, Columbia, MD, USA) with 5500 QTRAP triple quadrupole mass spectrometer (AB/SCIEX, Framingham, MA, USA); |
PMID | |
DOI | |
Citation | Park DI, Dournes C, Sillaber I, et al. Purine and pyrimidine metabolism: convergent evidence on chronic antidepressant treatment response in mice and humans. Sci Rep 2016;6:35317. |
Metabolite | myo-Inositol; Citric acid; Isocitric acid; Flavone; Phosphorylcholine; Carbamoyl phosphate; (S)-2-Methylmalate; Sarcosine; Glucosamine 6-phosphate; |